Dr Rui Campante Teles (Hospital Santa Cruz, Carnaxide, PT) joins us to discuss the implications of expanding TAVI into younger, lower-risk patients, with a focus on lifetime management strategies, coronary access, and long-term planning.

As TAVI continues to move into younger and lower-risk populations, the clinical calculus shifts considerably. Decisions made at the index procedure carry long-term consequences — from valve durability and future coronary access to the feasibility of redo interventions. Establishing a coherent lifetime management strategy from the outset has become an essential component of the heart team discussion in this evolving patient group.

Interview Questions:

1. What are the key considerations when evaluating a younger, lower-risk patient for TAVI rather than surgical AVR?
2. How should coronary access be factored into procedural planning in this population?
3. What does lifetime management look like in practice for a patient who receives TAVI in their 60s?
4. How should heart teams approach the prospect of future valve-in-valve procedures when selecting the index valve?
5. What are your take-home messages for heart teams expanding their TAVI programme into lower-risk patients?

Recorded on-site at EuroPCR 2026, Paris.
Editors: Jordan Rance
Videographer: David Ben-Harosh
Support: This is an independent interview produced by Radcliffe Cardiology.